Mark Mighell, MD
Orthopaedic Surgery · Temple Terrace, FLNPI 1528065323
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $2,955,225 of the $4,299,175 with a category attached, or 68.7%. Stryker accounts for 88.3% of it on its own, with 33 other manufacturers making up the rest. Among orthopaedic surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,427 payments — averaging $3012.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3.8M
- Encore Medical, LP$465K
- Medical Device Business Services, Inc.$15K
- Zimmer Biomet$6K
- Pacira Pharmaceuticals Incorporated$6K
- MVP Orthopedics Inc$3K
- plus $8K from 28 others
Across 20 payments — averaging $5691.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$80K
- Depuy Synthes Products, Inc.$29K
- Dunamis Medical, LLC$5K
What the payments were for
- Royalty or licence$2,955,22569%
- Consulting fees$1,170,28927%
- Travel & lodging$120,9293%
- Food & beverage$49,9931%
- Education$2,7400%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 1,162 | $3,796,764 |
| Encore Medical, LP | 95 | $464,801 |
| Medical Device Business Services, Inc. | 8 | $14,829 |
| Zimmer Biomet | 15 | $6,129 |
| Pacira Pharmaceuticals Incorporated | 6 | $5,694 |
| MVP Orthopedics Inc | 11 | $2,610 |
| Coastal Medical Technologies LLC | 20 | $1,570 |
| Dunamis Medical, LLC | 2 | $1,531 |
| Johnson & Johnson(2 entities) | 32 | $1,167 |
| Smith+Nephew | 20 | $914 |
| Baxter Healthcare | 7 | $484 |
| Arthrex | 4 | $418 |
| Sanara Medtech Inc. | 3 | $354 |
| Orthofix Medical, Inc. | 5 | $245 |
| Ossur Americas, Inc. | 1 | $225 |
| Biorez, Inc. | 1 | $187 |
| Heron Therapeutics, Inc. | 4 | $170 |
| Bioventus LLC | 7 | $134 |
| Exactech, Inc. | 1 | $125 |
| Trice Medical, Inc. | 3 | $124 |
| Amgen(2 entities) | 3 | $120 |
| Medtronic | 5 | $95 |
| Anika Therapeutics, Inc. | 1 | $95 |
| Davol Inc. | 1 | $70 |
| Biocomposites Inc | 1 | $54 |
| Restor3d, Inc. | 1 | $53 |
| Biedermann Motech, Inc. | 1 | $43 |
| Abbott | 1 | $39 |
| Coopersurgical, Inc. | 1 | $32 |
| Convatec Inc. | 1 | $29 |
| Heraeus Medical, LLC. | 1 | $20 |
| FX Shoulder Solutions, Inc | 1 | $19 |
| Acera Surgical, Inc. | 1 | $19 |
| Arthrosurface Incorporated | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REUNION$2,975,516
- TRUESIGHT$527,614
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$399,414
- AEQUALIS PERFORM$292,683
- DJO Surgical Turon Modular Shoulder System$205,398
- DJO SURGICAL$191,211
- MAKO$177,198
- TORNIER PERFORM REVERSED GLENOID$164,373
- AEQUALIS PERFORM REVERSED$125,130
- TORNIER PERFORM ANATOMIC AUGMENTED GLENOID$117,863
- SIMPLICITI$99,712
- TORNIER PERFORM REVERSED AUGMENTED GLENOID$95,760
- AEQUALIS$86,740
- AEQUALIS ASCEND FLEX$44,730
- DJO Surgical AltiVate Reverse$43,078
- DJO Surgical AltiVate Anatomic System$37,508
- DJO Surgical Alians Proximal Humerus Fracture Plate$34,880
- AEQUALIS REVERSED II$28,875
- INSPACE$21,919
- GRYPHON$14,625
How this compares
$4,299,175 in reported general payments places this provider in the 95th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisone | 94 | $436 |
| Meloxicam | 146 | $377 |
| Ibuprofen | 16 | $326 |
| Gabapentin | 25 | $283 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $240 |
| Methylprednisolone | 35 | $224 |
| Amoxicillin | 68 | $184 |
| Clindamycin Hcl | 24 | $138 |
| Tramadol Hcl | 16 | $78 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Temple Terrace
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- Thomas BernasekTemple Terrace$6.4M
- Kenneth GustkeTemple Terrace$5.2M
- Michael GarciaTemple Terrace$1.1M
- Christopher BakerTemple Terrace$575K
- John SmallTemple Terrace$467K
- Brian PalumboTemple Terrace$414K
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$34.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.